Glypican 3 - Revision history

Michael: /* Positive */

2017-12-07T16:29:25Z

Positive

← Older revision		Revision as of 16:29, 7 December 2017
Line 5:		Line 5:
	*[[Malignant melanoma]].<ref name=pmid25896897/>		*[[Malignant melanoma]].<ref name=pmid25896897/>
	*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/>		*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/>
			**Uncommon in adenocarcinoma of the lung ~3% of cases.<ref name=pmid26345955>{{Cite journal \| last1 = Yu \| first1 = X. \| last2 = Li \| first2 = Y. \| last3 = Chen \| first3 = SW. \| last4 = Shi \| first4 = Y. \| last5 = Xu \| first5 = F. \| title = Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance. \| journal = Genet Mol Res \| volume = 14 \| issue = 3 \| pages = 10185-92 \| month = Aug \| year = 2015 \| doi = 10.4238/2015.August.28.2 \| PMID = 26345955 }}</ref>
	*[[Yolk sac tumour]].		*[[Yolk sac tumour]].
	**More sensitive than [[alpha-fetoprotein]] (AFP).<ref name=pmid20438407>{{Cite journal \| last1 = Emerson \| first1 = RE. \| last2 = Ulbright \| first2 = TM. \| title = Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. \| journal = Pathology \| volume = 42 \| issue = 4 \| pages = 344-55 \| month = Jun \| year = 2010 \| doi = 10.3109/00313021003767355 \| PMID = 20438407 }}</ref>		**More sensitive than [[alpha-fetoprotein]] (AFP).<ref name=pmid20438407>{{Cite journal \| last1 = Emerson \| first1 = RE. \| last2 = Ulbright \| first2 = TM. \| title = Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. \| journal = Pathology \| volume = 42 \| issue = 4 \| pages = 344-55 \| month = Jun \| year = 2010 \| doi = 10.3109/00313021003767355 \| PMID = 20438407 }}</ref>

Michael: /* Positive */

2015-09-30T01:02:37Z

Positive

← Older revision		Revision as of 01:02, 30 September 2015
Line 10:		Line 10:
	===Images===		===Images===
	*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/>		*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/>

			==Positive or negative==
			*[[Choriocarcinoma]].

	==See also==		==See also==

Michael: /* Positive */

2015-09-30T00:55:21Z

Positive

← Older revision		Revision as of 00:55, 30 September 2015
Line 6:		Line 6:
	*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/>		*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/>
	*[[Yolk sac tumour]].		*[[Yolk sac tumour]].
			**More sensitive than [[alpha-fetoprotein]] (AFP).<ref name=pmid20438407>{{Cite journal \| last1 = Emerson \| first1 = RE. \| last2 = Ulbright \| first2 = TM. \| title = Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. \| journal = Pathology \| volume = 42 \| issue = 4 \| pages = 344-55 \| month = Jun \| year = 2010 \| doi = 10.3109/00313021003767355 \| PMID = 20438407 }}</ref>

	===Images===		===Images===

Michael: tweak

2015-09-30T00:54:02Z

tweak

← Older revision		Revision as of 00:54, 30 September 2015
Line 1:		Line 1:
	'''Glypican 3''' is a common [[immunostain]] used in [[gastrointestinal pathology]] and [[~~genituorinary~~ pathology]].		'''Glypican 3''', abbreviated '''GPC3''',<ref>{{OMIM\|300037}}</ref> is a common [[immunostain]] used in [[gastrointestinal pathology]] and [[genitourinary pathology]].

	==Positive==		==Positive==

Michael: /* Positive */

2015-09-30T00:51:29Z

Positive

← Older revision		Revision as of 00:51, 30 September 2015
Line 3:		Line 3:
	==Positive==		==Positive==
	*[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal \| last1 = Aydin \| first1 = O. \| last2 = Yildiz \| first2 = L. \| last3 = Baris \| first3 = S. \| last4 = Dundar \| first4 = C. \| last5 = Karagoz \| first5 = F. \| title = Expression of Glypican 3 in low and high grade urothelial carcinomas. \| journal = Diagn Pathol \| volume = 10 \| issue = \| pages = 34 \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0266-4 \| PMID = 25896897 }}</ref>		*[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal \| last1 = Aydin \| first1 = O. \| last2 = Yildiz \| first2 = L. \| last3 = Baris \| first3 = S. \| last4 = Dundar \| first4 = C. \| last5 = Karagoz \| first5 = F. \| title = Expression of Glypican 3 in low and high grade urothelial carcinomas. \| journal = Diagn Pathol \| volume = 10 \| issue = \| pages = 34 \| month = \| year = 2015 \| doi = 10.1186/s13000-015-0266-4 \| PMID = 25896897 }}</ref>
			*[[Malignant melanoma]].<ref name=pmid25896897/>
			*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/>
			*[[Yolk sac tumour]].

			===Images===
			*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/>

	==See also==		==See also==

Michael: create

2015-09-30T00:49:07Z

create

New page

'''Glypican 3''' is a common [[immunostain]] used in [[gastrointestinal pathology]] and [[genituorinary pathology]].

==Positive==
*[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal | last1 = Aydin | first1 = O. | last2 = Yildiz | first2 = L. | last3 = Baris | first3 = S. | last4 = Dundar | first4 = C. | last5 = Karagoz | first5 = F. | title = Expression of Glypican 3 in low and high grade urothelial carcinomas. | journal = Diagn Pathol | volume = 10 | issue = | pages = 34 | month = | year = 2015 | doi = 10.1186/s13000-015-0266-4 | PMID = 25896897 }}</ref>

==See also==
*[[Immunohistochemistry]].

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]